glp-1 weight loss without exercise vs. Exercise: Two Paths to GLP-1 Receptor Agonists - Stay
Description
Treat GLP-1s as a support tool, not a shortcut
Oral semaglutide 50 mg In people with obesity without T2D, a 68-week phase 3 trial (OASIS-1) assessed the safety and efficacy of oral semaglutide 50 mg once daily vs
This approach maintains more stable blood levels and may reduce side effects
The better question is: How can you support the bodys natural metabolic systems as well as possible
